MarketCap
Facebook
X
Telegram
The Scotts Miracle-Gro Company Cash Flow 2025-2007 | SMG
Brief overview of The Scotts Miracle-Gro Company's cash generation
Cash flow changes are traced through the five latest available reports from 2021 to 2025.
Cash from core operations added +36.8% to reach $371.3 million. Average growth of 8.1% remains healthy.
Operating cash flow was above zero 4 times out of five. Most, but not all, periods generated cash.
Operating cash flow margin improved from 5.5% to 10.9%. The quality of revenue growth strengthened.
About $450.1 million was released from working capital. The benefit supports cash flow but may be temporary.
Overall picture
The Scotts Miracle-Gro Company's cash generation remains workable and supports the business, though some uses of cash limit flexibility.
Annual Cash Flow The Scotts Miracle-Gro Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
371 M | 668 M | 531 M | -129 M | 272 M | 558 M | 227 M | 342 M | 363 M | 244 M | 247 M | 241 M | 342 M | 153 M | 122 M | 296 M | 265 M | 201 M | - |
Depreciation & Amortization |
62.7 M | 80.6 M | 92.5 M | 105 M | 93.8 M | 94.7 M | 89.3 M | 83.4 M | 73.8 M | 70.4 M | 69 M | 64.4 M | 66.1 M | 62.4 M | 60.8 M | 48.5 M | 47.9 M | 53.9 M | - |
Accounts Payables |
229 M | 255 M | 271 M | 423 M | 609 M | 391 M | 214 M | 150 M | 153 M | 166 M | 198 M | 193 M | 138 M | 152 M | 150 M | 142 M | 190 M | - | - |
Accounts Receivables |
187 M | 177 M | 304 M | 299 M | 483 M | 475 M | 224 M | 226 M | 198 M | 196 M | 191 M | 224 M | 207 M | 331 M | 324 M | 351 M | 384 M | - | - |
Total Inventories |
593 M | 588 M | 880 M | 1.34 B | 1.13 B | 622 M | 540 M | 481 M | 408 M | 448 M | 408 M | 385 M | 325 M | 415 M | 387 M | 353 M | 459 M | - | - |
All numbers in USD currency
Quarterly Cash Flow The Scotts Miracle-Gro Company
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-150 M | -370 M | -370 M | - | - | - | -445 M | - | - | - | -343 M | - | - | - | -432 M | -680 M | - | - | -421 M | -207 M | -700 M | - | - | 42.5 M | -607 M | - | -318 M | -77.7 M | -546 M | -318 M | -233 M | -3.4 M | -483 M | -233 M | -210 M | 91.6 M | -489 M | -210 M | -210 M | -28.9 M | -628 M | -210 M | - | 24.2 M | -649 M | - | -267 M | 34.3 M | -615 M | -267 M | -180 M | 143 M | -545 M | -180 M | -169 M | 115 M | -620 M | -169 M | -201 M | -13.5 M | -604 M | -201 M | 156 M |
Depreciation & Amortization |
31 M | 15.6 M | 15.6 M | - | - | - | 15.8 M | - | - | - | 16.1 M | - | - | - | 17.5 M | 50.3 M | - | - | 15.7 M | 47 M | 31.3 M | - | - | 45.4 M | 30.1 M | - | 14.8 M | 41.8 M | 27.9 M | 14.8 M | 14 M | 39.2 M | 25.5 M | 14 M | 12.7 M | 41.4 M | 27.6 M | 12.7 M | 14 M | 40.2 M | 27.3 M | 14 M | - | 38.2 M | 24.9 M | - | 12.5 M | 37.8 M | 25.7 M | 12.5 M | 13 M | 41 M | 27.4 M | 13 M | 13.6 M | 39.6 M | 25.4 M | 13.6 M | 12.9 M | 37.3 M | 24.6 M | 12.9 M | 36.3 M |
Accounts Payables |
386 M | 284 M | 284 M | 221 M | 262 M | 396 M | 284 M | 255 M | 317 M | 440 M | 332 M | 271 M | 366 M | 416 M | 367 M | 423 M | 291 M | 508 M | 499 M | 609 M | 468 M | 609 M | - | 391 M | 391 M | 391 M | 309 M | 214 M | 214 M | 309 M | 237 M | 150 M | 150 M | 237 M | 223 M | 153 M | 153 M | 223 M | 218 M | 131 M | 166 M | 256 M | - | 193 M | 193 M | 198 M | 220 M | 193 M | 193 M | 220 M | 231 M | 138 M | 138 M | 231 M | 186 M | 152 M | 152 M | 186 M | 220 M | 150 M | 150 M | 220 M | 230 M |
Accounts Receivables |
767 M | 194 M | 194 M | 161 M | 574 M | 799 M | 173 M | 177 M | 505 M | 877 M | 288 M | 304 M | 718 M | 1.04 B | 311 M | 299 M | 675 M | 990 M | 347 M | 483 M | 1.06 B | 483 M | - | 475 M | 475 M | 475 M | 193 M | 224 M | 224 M | 193 M | 164 M | 226 M | 226 M | 164 M | 128 M | 198 M | 198 M | 128 M | 176 M | 127 M | 196 M | 229 M | - | 158 M | 158 M | 191 M | 185 M | 224 M | 224 M | 185 M | 158 M | 207 M | 207 M | 158 M | 168 M | 331 M | 331 M | 168 M | 166 M | 324 M | 324 M | 166 M | 674 M |
Total Inventories |
696 M | 847 M | 847 M | 543 M | 544 M | 773 M | 845 M | 588 M | 607 M | 824 M | 1.17 B | 880 M | 885 M | 1.13 B | 1.53 B | 1.34 B | 1.41 B | 1.59 B | 1.07 B | 1.13 B | 963 M | 1.13 B | - | 622 M | 622 M | 622 M | 866 M | 540 M | 540 M | 866 M | 745 M | 481 M | 481 M | 745 M | 696 M | 408 M | 408 M | 696 M | 686 M | 395 M | 448 M | 756 M | - | 396 M | 396 M | 408 M | 683 M | 385 M | 385 M | 683 M | 606 M | 325 M | 325 M | 606 M | 647 M | 415 M | 415 M | 647 M | 655 M | 387 M | 387 M | 655 M | 462 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company The Scotts Miracle-Gro Company, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Agricultural inputs sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M |  China |
 |
Origin Agritech Limited
SEED
|
$ 1.0 | - | $ 7.49 M | China |
 |
CVR Partners, LP
UAN
|
$ 128.99 | 0.78 % | $ 1.36 B |  USA |
 |
American Vanguard Corporation
AVD
|
$ 2.39 | -2.85 % | $ 67.9 M | USA |
 |
CF Industries Holdings
CF
|
$ 125.19 | -0.46 % | $ 20.3 B | USA |
 |
FMC Corporation
FMC
|
$ 10.71 | -9.47 % | $ 1.34 B | USA |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
The Mosaic Company
MOS
|
$ 22.12 | -2.85 % | $ 7.02 B | USA |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
Bioceres Crop Solutions Corp.
BIOX
|
$ 0.36 | 11.46 % | $ 22.8 M |  Argentina |
 |
Corteva
CTVA
|
$ 78.71 | -11.93 % | $ 53.5 B | USA |
 |
ICL Group Ltd
ICL
|
$ 5.06 | -2.32 % | $ 6.53 B |  Israel |
 |
Arcadia Biosciences
RKDA
|
$ 0.63 | -3.83 % | $ 862 K | USA |
 |
Intrepid Potash
IPI
|
$ 33.96 | -3.85 % | $ 442 M | USA |
 |
Nutrien Ltd.
NTR
|
$ 69.07 | -2.33 % | $ 33.6 B |  Canada |